{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11140732", "DateCompleted": {"Year": "2001", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "19"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0960-894X", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2001", "Month": "Jan", "Day": "08"}}, "Title": "Bioorganic & medicinal chemistry letters", "ISOAbbreviation": "Bioorg Med Chem Lett"}, "ArticleTitle": "Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.", "Pagination": {"StartPage": "51", "EndPage": "54", "MedlinePgn": "51-4"}, "Abstract": {"AbstractText": ["A series of diarylamines, diaryl and arylbenzyl ethers based on combretastatin A-4 was prepared and evaluated for anticancer activity. 2-Methoxy-5-(3',4',5'-trimethoxyphenoxymethyl)phenol was the most active (IC50, K562 20 nM) and caused significant G2/M cell cycle arrest."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, UMIST, Manchester, UK. lawrencenj1@cardiff.ac.uk"}], "Identifier": [], "LastName": "Lawrence", "ForeName": "N J", "Initials": "NJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rennison", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Woo", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "McGown", "ForeName": "A T", "Initials": "AT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hadfield", "ForeName": "J A", "Initials": "JA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem Lett", "NlmUniqueID": "9107377", "ISSNLinking": "0960-894X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Ethers"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "I5590ES2QZ", "NameOfSubstance": "fosbretabulin"}, {"RegistryNumber": "SML2Y3J35T", "NameOfSubstance": "Colchicine"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Colchicine"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Ethers"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Binding"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Stilbenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "1", "Day": "5", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "4", "Day": "3", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "1", "Day": "5", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11140732", "10.1016/s0960-894x(00)00596-5", "S0960-894X(00)00596-5"]}}], "PubmedBookArticle": []}